Beta BionicsBBNX +1.00%10 Days Inventory is 185.33 as of Mar. 2026, which is 104% above its 10-year median of 90.92. GuruFocus rates BBNX with a GF Score™ of 10/100. The stock has 3 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Beta Bionics ranks better than 60.91% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Beta Bionics's Average Total Inventories for the
three
months ended in Mar. 2026 was $22.7 Mil. Beta Bionics's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $11.2 Mil.
Hence, Beta Bionics's Days Inventory for the
three
months ended in Mar. 2026 was 185.33.
The historical rank and industry rank for Beta Bionics's Days Inventory or its related term are showing as below:
BBNX'
s Days Inventory Range Over the Past 10 Years
Min: 79.91 Med: 90.92 Max: 152.81
Current: 152.81
During the past 4 years, Beta Bionics's highest Days Inventory was 152.81. The lowest was 79.91. And the median was 90.92.
BBNX's Days Inventory is ranked better than 60.91% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 179.115
vs BBNX: 152.81
Beta Bionics's Days Inventory
increased
from Mar. 2025 (152.91) to Mar. 2026 (185.33).
It might indicate that Beta Bionics's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Beta Bionics's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.49.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Beta Bionics's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.82.
Beta Bionics (NAS:BBNX) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Beta Bionics's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Beta Bionics's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Beta Bionics Days Inventory Related Terms
Beta Bionics Days Inventory Historical Data
* Premium members only.
The historical data trend for Beta Bionics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BBNX vs CBLL, SIBN, TCMD: Days Inventory Comparison
For the Medical Devices subindustry, Beta Bionics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beta Bionics Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Beta Bionics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Beta Bionics's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beta Bionics (BBNX) has a Days Inventory of 185.33 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Beta Bionics and its competitors. This is 104% above median its historical median of 90.92. Over the past decade, Beta Bionics' Days Inventory has ranged from 79.91 to 152.81. According to the industry distribution chart, Beta Bionics ranks #308 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 39.1%.
Is Beta Bionics' Days Inventory too high?
Beta Bionics' current Days Inventory of 185.33 is 104% above median its 10-year median of 90.92. Over the past 10 years, this metric has ranged from a low of 79.91 to a high of 152.81. The Medical Devices & Instruments industry median Days Inventory is 179.12. Beta Bionics' value of 185.33 is 3.5% above this industry median. Based on the distribution chart, Beta Bionics ranks #308 out of 788 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Beta Bionics has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Beta Bionics' Days Inventory compare to CBLL and SIBN?
According to the Medical Devices & Instruments industry distribution chart, Beta Bionics ranks #308 out of 788 companies for Days Inventory. This puts Beta Bionics in the upper half of its industry. The industry median Days Inventory is 179.12. Beta Bionics' value of 185.33 is 3.5% above this benchmark. Historically, Beta Bionics' own Days Inventory has ranged from 79.91 to 152.81 over the past decade. While the company's 10-year median is 90.92 vs. the industry median of 179.12, Beta Bionics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.12, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beta Bionics's current Days Inventory of 185.33 is 3.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Beta Bionics and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beta Bionics's current Days Inventory is 185.33, which is 104% above median its own 10-year median of 90.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beta Bionics stock overvalued right now?
Beta Bionics (BBNX) has a current Days Inventory of 185.33. The current Days Inventory is 185.33, which is 104% above median its 10-year median of 90.92 and 3.5% above the Medical Devices & Instruments industry median of 179.12. Beta Bionics' overall GF Score™ is 10/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Beta Bionics (BBNX), the current Days Inventory is 185.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
10GF Score
Get the complete analysis for BBNX
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BBNX has been successfully added to your 
